Literature DB >> 2169885

Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase.

P Aroca1, J C Garcia-Borron, F Solano, J A Lozano.   

Abstract

A protein that catalyzes the decoloration of dopachrome has been partially purified from B16 mouse melanoma tumors. The enzyme is preferentially associated to the melanosomes, but it is also found in the microsomal and cytosolic fractions of cellular homogenates. The protein is clearly different from tyrosinase, and should be related to the dopachrome oxidoreductase (Barber et al. (1984) J. Invest. Dermatol. 83, 145-149) and the dopachrome conversion factor (Korner and Pawelek (1980) J. Invest. Dermatol. 75, 192-195) since the reaction product of dopachrome conversion is 5,6-dihydroxyindole-2-carboxylic acid. The protein appears to have an oligomeric structure, with a molecular mass slightly higher than 300 kDa estimated by gel filtration, whereas the molecular mass of the monomer might be approx. 46 kDa estimated by SDS-PAGE electrophoresis. Its Km for dopachrome is around 100 microM. The enzyme is competitively inhibited by indoles and is unaffected by metal chelators. It also has the ability to increase the amount of melanin formed from L-tyrosine by melanoma tyrosinase, and therefore, cannot be considered an 'indole blocking factor' as was suggested for the related dopachrome oxidoreductase. Since the reaction catalyzed by the enzyme is a tautomeric shift on dopachrome, we would propose dopachrome tautomerase (EC 5.3.2.3) as the most precise and informative name.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169885     DOI: 10.1016/0304-4165(90)90088-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  The action of glycosylases on dopachrome (2-carboxy-2,3-dihydroindole-5,6-quinone) tautomerase.

Authors:  P Aroca; J H Martinez-Liarte; F Solano; J C García-Borrón; J A Lozano
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  Purification and N-glycosylation analysis of melanoma antigen dopachrome tautomerase.

Authors:  Christopher J Vavricka; Keith W Ray; Bruce M Christensen; Jianyong Li
Journal:  Protein J       Date:  2010-04       Impact factor: 2.371

Review 3.  Melanization in living organisms: a perspective of species evolution.

Authors:  Christopher J Vavricka; Bruce M Christensen; Jianyong Li
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

4.  Identification of Drosophila melanogaster yellow-f and yellow-f2 proteins as dopachrome-conversion enzymes.

Authors:  Qian Han; Jianmin Fang; Haizhen Ding; Jody K Johnson; Bruce M Christensen; Jianyong Li
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

5.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

6.  A new dopachrome-rearranging enzyme from the ejected ink of the cuttlefish Sepia officinalis.

Authors:  A Palumbo; M d'Ischia; G Misuraca; L De Martino; G Prota
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

Review 7.  Actinobacterial melanins: current status and perspective for the future.

Authors:  Panchanathan Manivasagan; Jayachandran Venkatesan; Kannan Sivakumar; Se-Kwon Kim
Journal:  World J Microbiol Biotechnol       Date:  2013-04-18       Impact factor: 3.312

8.  5,6-Dihydroxyindole-2-carboxylic acid is incorporated in mammalian melanin.

Authors:  K Tsukamoto; A Palumbo; M D'Ischia; V J Hearing; G Prota
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Molecular mechanism for catalysis by a new zinc-enzyme, dopachrome tautomerase.

Authors:  F Solano; C Jiménez-Cervantes; J H Martínez-Liarte; J C García-Borrón; J R Jara; J A Lozano
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Specificity of dopachrome tautomerase and inhibition by carboxylated indoles. Considerations on the enzyme active site.

Authors:  P Aroca; F Solano; J C Garcia-Borrón; J A Lozano
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.